BIOXODES has a total of 13 patent applications. Its first patent ever was published in 2019. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are IMMUNOBIOLOGY RES INST INC, IGENEON KREBS IMMUNTHERAPIE and ENSOL BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Godfroid Edmond | 12 |
#2 | Guyaux Michel | 12 |
#3 | Derochette Sandrine | 9 |
#4 | Demoulin Stéphanie | 8 |
#5 | Tassignon Joël | 8 |
#6 | Pireaux Valérie | 5 |
#7 | Pireaux Valerie | 4 |
#8 | Tassignon Joel | 4 |
#9 | Demoulin Stephanie | 4 |
#10 | Valérie Pireaux | 1 |
Publication | Filing date | Title |
---|---|---|
US2021070817A1 | Anticoagulant fusion proteins and uses thereof | |
CN111936512A | Anticoagulant proteins and their use to treat diseases associated with neutrophil activation |